On May 12, 2026, a coalition of 56 patient and professional organizations made it official: polycystic ovary syndrome is being renamed. Here’s what the PCOS to PMOS terminology change means, why it happened, and what patients can expect as the transition unfolds.
For decades, PCOS — Polycystic Ovary Syndrome — has been one of the most misunderstood diagnoses in women’s health.
Despite the name, many patients diagnosed with PCOS do not actually have ovarian cysts. And for many women, PCOS symptoms extend far beyond fertility or reproductive health alone: fatigue, insulin resistance, acne, weight fluctuations, brain fog, irregular periods, inflammation.
Now, after a 14-year consensus process involving more than 14,300 patients and health professionals across six continents — published in The Lancet on May 12, 2026 — the name is changing. And the science behind that decision is worth understanding.
What Is PMOS — and How Is It Different From PCOS?
Polyendocrine metabolic ovarian syndrome (PMOS) is the new official name for the condition previously known as polycystic ovary syndrome (PCOS).
On May 12, 2026, a coalition of 56 patient and professional organizations announced the PCOS to PMOS terminology change following a landmark international consensus effort led by researchers at Monash University. It represents one of the most significant reframings of a women’s health condition in recent medical history.
The rename is not a rebranding exercise. It reflects a fundamental shift in how the condition is understood: not primarily as an ovarian or reproductive disorder, but as a whole-body hormonal and metabolic condition. The addition of “metabolic” and “polyendocrine” to the name directly addresses what PCOS vs PMOS terminology experts have long debated — that the old label centered the ovaries while the actual condition affects far more.
“The name PCOS has historically centered the ovaries, but for many patients, the condition affects nearly every aspect of their health,” says Dr. James Gohar, Co-Founder and Head OB/GYN at Viva Eve. “The shift to PMOS reflects a broader and more accurate understanding — this is often a metabolic and hormonal condition, not simply a reproductive one.”
Does the PCOS to PMOS Name Change Affect My Diagnosis or Treatment?
No. Diagnostic criteria and PCOS treatment protocols are not affected by the rename. If you have a PCOS diagnosis, nothing about your care changes because of this announcement.
The widely used Rotterdam criteria — which requires meeting two of three factors (irregular ovulation, elevated androgens, and polycystic ovarian morphology on ultrasound) — remain the standard for diagnosis. Fertility care for PMOS follows the same clinical approach as PCOS care.
What will change — gradually — is the language you see in medical records, lab reports, clinic materials, and patient education resources. The transition is intentional and structured around three years of education and adoption across the medical community.
So if your doctor still says “PCOS,” or if your lab report still uses the old abbreviation, that’s normal. Both names appearing side by side is expected during this transition period. It doesn’t mean your provider is behind — it means the rollout is still underway.
Is the PCOS to PMOS Rename a Global Change?
Yes — and that’s what makes this moment genuinely significant.
The consensus that produced the rename was explicitly international in scope. The process included iterative global surveys with responses from over 14,300 patients and multidisciplinary health professionals “from all world regions,” and was led by Professor Helena Teede of Monash University alongside co-leads from Finland and the United States, with 56 patient and professional organizations participating — including the Endocrine Society.
The condition affects more than 170 million women worldwide, or more than one in eight. The rename was designed from the outset to travel.
That said, global adoption is a process, not a single moment. Here’s what the roadmap looks like:
The Lancet publication — the scientific and clinical foundation for the rename — is already in the hands of providers, researchers, and medical institutions worldwide. The paper was also presented at the European Congress of Endocrinology in Prague, signaling formal entry into the international clinical community.
WHO and ICD integration — formal engagement with the World Health Organization is already underway to progress integration into disease classification systems, including the ICD. The International Guideline, already used in 195 countries, will next be updated in 2028 — and PMOS integration is planned for that update.
A three-year transition roadmap — the transition period is supported by a major international education and awareness campaign reaching health professionals, governments, and researchers around the world.
What this means practically: if you’re a patient in the UK, Australia, Canada, or anywhere else, the rename applies to you — but how quickly your local healthcare system reflects it will vary. Updates to clinical guidelines, medical education, and international disease classification systems are planned to ensure the new terminology is adopted consistently worldwide, but that consistency will take time to reach every clinic, lab report, and EHR.
The short answer to “does this affect me if I’m not in the US?” is yes. The timeline for seeing it in your own care will depend on where you are and how quickly your local systems move.
Why Did Experts Push to Change the PCOS Terminology?
One of the biggest misconceptions surrounding PCOS symptoms and diagnosis has always been the assumption that ovarian cysts are required. In reality, many people diagnosed with PCOS do not have polycystic-appearing ovaries on ultrasound at all.
The “cysts” associated with PCOS are not typically dangerous cysts requiring surgery. They are usually immature follicles — small sacs where eggs begin developing but do not fully mature or ovulate. Hyperandrogenism — elevated androgen levels, including testosterone — can interfere with ovulation and contribute to these follicle patterns.
For many experts, this is precisely why PCOS vs PMOS terminology became a serious clinical conversation. The condition extends well beyond the ovaries, and the diagnostic criteria have always reflected that. The name finally catches up.
What PCOS Symptoms Are Connected to Metabolic Health?
Understanding the connection between PCOS symptoms and metabolic dysfunction is central to the PCOS to PMOS terminology shift.
Many — though not all — people with this condition experience insulin resistance, meaning the body’s cells do not respond to insulin efficiently. As a result, the body may produce higher levels of insulin to compensate. Over time, elevated insulin can drive hyperandrogenism — increased androgen production — which worsens a wide range of PCOS symptoms:
- Irregular or absent periods
- Acne and oily skin
- Excess facial or body hair (hirsutism)
- Ovulatory dysfunction
- Weight fluctuations
Many patients also experience PCOS symptoms that don’t initially appear reproductive at all — but are directly tied to insulin resistance and metabolic health:
- Persistent fatigue, particularly after meals
- Brain fog and difficulty concentrating
- Intense sugar or carbohydrate cravings
- Skin tags
- Darkened skin patches (acanthosis nigricans)
For many clinicians, PMOS better reflects this whole-body picture. For many patients, it validates what they’ve always known: something larger was being missed.
Is PMOS a Metabolic Condition? What’s the Cardiometabolic Risk?
Increasingly, yes — at least in part.
Historically, PCOS was often framed as a reproductive disorder because many patients first sought care for irregular periods or fertility challenges. But research has continued to confirm that metabolic health plays a major role for many patients — and that the long-term stakes extend beyond reproduction.
Insulin resistance, inflammation, dyslipidemia, and blood sugar dysregulation are all commonly associated with PMOS. Taken together, these factors contribute to meaningful cardiometabolic risk, including elevated likelihood of developing Type 2 diabetes and cardiovascular disease over time.
That understanding is reshaping how providers approach long-term PCOS treatment — and why the rename to PMOS matters clinically, not just semantically.
“One of the most important things patients should know is that their symptoms are real — and they deserve comprehensive care,” says Dr. Saloni Mathur, Ob/Gyn at Viva Eve. “Whether we call it PCOS or PMOS, our goal is to look at the full picture: hormonal health, metabolic health, fertility goals, and long-term wellness.”
How Is PCOS Treatment Changing Under the PMOS Framework?
Hormonal birth control remains an effective, evidence-based PCOS treatment option for managing cycle irregularity and androgen-related symptoms — and that hasn’t changed.
But providers are increasingly recognizing that comprehensive PMOS care must also address the metabolic root of the condition. Modern PCOS treatment plans may now include:
- Insulin resistance management — through lifestyle changes, blood sugar monitoring, or insulin-sensitizing medications and supplements (such as metformin or myo-inositol)
- Nutritional counseling — particularly protein-forward eating patterns that blunt blood sugar spikes
- Resistance training — building lean muscle to improve glucose metabolism and counter hyperandrogenism
- Cardiometabolic risk monitoring — lipid panels, A1C, inflammatory markers
- Fertility planning — especially for patients managing ovulatory dysfunction
- Hormonal symptom management — addressing acne, hair changes, and cycle regularity
The PCOS to PMOS terminology shift makes this whole-body expectation explicit. It reframes what comprehensive care should look like — and gives patients language to ask for it.
Why Does the PCOS vs PMOS Debate Matter Beyond the Name?
Whether you first heard about the PCOS to PMOS terminology change in a clinical setting or through a headline, the larger point is the same.
For years, many women with PCOS felt their symptoms were minimized, misunderstood, or treated in isolation. PCOS symptoms that weren’t reproductive — fatigue, metabolic changes, skin issues, cognitive difficulties — were often dismissed or attributed to other causes.
The PMOS rename signals to patients, providers, and the healthcare system that this condition deserves to be understood in full. PMOS can affect:
- Energy levels and metabolism
- Mental health and cognitive clarity
- Skin and systemic inflammation
- Cardiovascular and cardiometabolic health
- Fertility and hormonal balance
- Overall quality of life
That reframing matters. It shifts the conversation from “a reproductive issue” to a more accurate picture of what patients are actually living with.
“The move away from ‘polycystic ovary syndrome’ is more than a name change — it’s a step toward reducing stigma, improving understanding, and helping patients feel seen for the full complexity of what they’re living with,” says Tamsin Jordan, Registered Dietitian at Viva Eve. “PMOS affects hormones, metabolism, mental health, skin, and the reproductive system. It has always demanded a holistic approach. Now the name finally reflects that.”
How Do I Advocate for Better PCOS or PMOS Care?
If your PCOS symptoms feel incompletely addressed — or if your care has focused only on cycle regulation without considering metabolic health — it may help to ask your provider about:
- Insulin resistance screening — fasting insulin, not just blood glucose
- Hemoglobin A1C — three-month average blood sugar
- Lipid panel — to assess cardiometabolic risk
- Hormone and androgen evaluation — including testosterone and DHEA
- Rotterdam criteria review — to confirm whether all three diagnostic criteria have been evaluated
- Fertility considerations — if conception is a current or future goal
- Long-term metabolic health planning
Tracking your symptoms, asking direct questions, and seeking a provider who takes a whole-body approach to PCOS treatment can make a meaningful difference.
The PCOS to PMOS terminology change is a long-overdue correction. But the most important shift isn’t the abbreviation — it’s the standard of care the new name demands.
Have questions about PCOS, PMOS, or what the terminology change means for your care? Our team at Viva Eve is here to help. Book an appointment at our Forest Hills, Queens or Midtown East, Manhattan location.
